Literature DB >> 21722990

Control of an outbreak of carbapenem-resistant Pseudomonas aeruginosa in a haemato-oncology unit.

M Nagao1, Y Iinuma, J Igawa, T Saito, K Yamashita, T Kondo, A Matsushima, S Takakura, A Takaori-Kondo, S Ichiyama.   

Abstract

An outbreak of a multidrug-resistant Pseudomonas aeruginosa producing metallo-β-lactamase (MBLPA) in a haemato-oncology unit was controlled using multidisciplinary interventions. The present study assesses the effects of these interventions by active surveillance of the incidence of MBLPA infection at the 1,240-bed tertiary care Kyoto University Hospital in Kyoto, Japan. Infection control strategies in 2004 included strengthening contact precautions, analysis of risk factors for MBLPA infection and cessation of urine collection. However, new MBLPA infections were identified in 2006, which prompted enhanced environmental cleaning, routine active surveillance, and restricting carbapenem usage. Between 2004 and 2010, 17 patients in the unit became infected with indistinguishable MBLPA strains. The final five infected patients were found by routine active surveillance, but horizontal transmission was undetectable. The MBLPA outbreak in the haemato-oncology unit was finally contained in 2008.
Copyright © 2011 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21722990     DOI: 10.1016/j.jhin.2011.04.018

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  9 in total

Review 1.  A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

Review 2.  Bacterial Infections in Hematopoietic Stem Cell Transplant Recipients.

Authors:  Elisa Balletto; Małgorzata Mikulska
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-07-01       Impact factor: 2.576

Review 3.  Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa.

Authors:  Duck Jin Hong; Il Kwon Bae; In-Ho Jang; Seok Hoon Jeong; Hyun-Kyung Kang; Kyungwon Lee
Journal:  Infect Chemother       Date:  2015-06-30

4.  Surveillance and correlation of antimicrobial usage and resistance of Pseudomonas aeruginosa: a hospital population-based study.

Authors:  Jiancheng Xu; Xiumei Duan; Hui Wu; Qi Zhou
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

5.  Control of Carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa in Healthcare Facilities: A Systematic Review and Reanalysis of Quasi-experimental Studies.

Authors:  Sara Tomczyk; Veronica Zanichelli; M Lindsay Grayson; Anthony Twyman; Mohamed Abbas; Daniela Pires; Benedetta Allegranzi; Stephan Harbarth
Journal:  Clin Infect Dis       Date:  2019-02-15       Impact factor: 9.079

6.  Anti-biofilm Agents against Pseudomonas aeruginosa: A Structure-Activity Relationship Study of C-Glycosidic LecB Inhibitors.

Authors:  Roman Sommer; Katharina Rox; Stefanie Wagner; Dirk Hauck; Sarah S Henrikus; Shelby Newsad; Tatjana Arnold; Thomas Ryckmans; Mark Brönstrup; Anne Imberty; Annabelle Varrot; Rolf W Hartmann; Alexander Titz
Journal:  J Med Chem       Date:  2019-10-11       Impact factor: 7.446

7.  An equation to estimate 24-hour total urine protein excretion rate in patients who underwent urine protein testing.

Authors:  Fan Yang; Jing-Song Shi; Si-Wen Gong; Xiao-Dong Xu; Wei-Bo Le
Journal:  BMC Nephrol       Date:  2022-01-29       Impact factor: 2.388

8.  Detection of metallo-β-lactamases-encoding genes among clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital, Kathmandu, Nepal.

Authors:  Mahesh Acharya; Prabhu R Joshi; Kamal Thapa; Rajan Aryal; Trishna Kakshapati; Supriya Sharma
Journal:  BMC Res Notes       Date:  2017-12-08

9.  Spot urine protein/creatinine ratio as a reliable estimate of 24-hour proteinuria in patients with immunoglobulin A nephropathy, but not membranous nephropathy.

Authors:  Seiji Kobayashi; Hoichi Amano; Hiroyuki Terawaki; Makoto Ogura; Yoshindo Kawaguchi; Takashi Yokoo
Journal:  BMC Nephrol       Date:  2019-08-06       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.